According to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology’s 48th Annual Meeting in Philadelphia:
Prostate cancer patients treated with either radiation or surgery who use hormone therapy for longer than six months do not survive any longer than patients who use the treatment for a shorter amount of time.
Most high risk prostate cancer patients are currently being treated with two or more years of hormone therapy based on a decade-old study results.
The new findings, headed by Cliff Robinson, M.D., lead author of the study and a radiation oncologist at Cleveland Clinic in Cleveland, …read more